← Browse by Condition
Medical Condition

nasal obstruction

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for nasal obstruction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — nasal obstruction Clinical Trials

How many clinical trials are currently recruiting for nasal obstruction?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for nasal obstruction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for nasal obstruction?
nasal obstruction research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a nasal obstruction clinical trial?
Eligibility criteria for nasal obstruction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
Laboratoires Gilbert 1 trial
FRANK DECLAU 1 trial
Cumhuriyet University Hospital 1 trial
Bayer 1 trial
Washington University School of Medicine 1 trial

Recruiting Clinical Trials

NCT05494346
Recruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Enrollment
101 pts
Location
France
Sponsor
Laboratoires Gilbert
View Trial →
NCT03925389
Recruiting

Outcome Analysis in Septorhinoplasty

Enrollment
750 pts
Location
Belgium
Sponsor
FRANK DECLAU
View Trial →
NCT07531810
Recruiting

Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Cumhuriyet University Hospital
View Trial →
NCT07582328 Phase 2
Recruiting

A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults

Enrollment
120 pts
Location
Canada
Sponsor
Bayer
View Trial →
NCT06830109 Phase 2
Recruiting

Nasal Obstruction With Oxymetazoline and Corticosteroids

Enrollment
80 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology